Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 12

Trial Status

Completed1
Terminated1

Role Distribution

Principal Investigator2
PI Rate100%

Activity Timeline

Clinical Trials (2)

NCT00040781Phase 1Completed
Gefitinib in Treating Children With Refractory Solid Tumors
Unspecified Childhood Solid Tumor, Protocol Specific
Principalinvestigator
NCT01088763Phase 1Terminated
Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia
Childhood Atypical Teratoid/Rhabdoid TumorChildhood Central Nervous System ChoriocarcinomaChildhood Central Nervous System Germinoma+43 more
Principalinvestigator

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Maryam Fouladi

Children's Oncology Group

Related
5 trials

Shared therapeutic areas:

Recurrent Childhood MedulloblastomaRecurrent Childhood Supratentorial Primitive Neuroectodermal TumorUnspecified Childhood Solid Tumor, Protocol Specific+20 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score15%

David Maloney

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

Related
11 trials

Shared therapeutic areas:

Recurrent Childhood Acute Lymphoblastic LeukemiaRecurrent Childhood Grade III Lymphomatoid GranulomatosisRecurrent Childhood Large Cell Lymphoma+5 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score5%

Brenda Sandmaier

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

Related
12 trials

Shared therapeutic areas:

Recurrent Childhood Acute Lymphoblastic LeukemiaRecurrent Childhood Lymphoblastic LymphomaRecurrent Childhood Anaplastic Large Cell Lymphoma+5 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score5%

Marco Mielcarek

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

Related
5 trials

Shared therapeutic areas:

Recurrent Childhood Acute Lymphoblastic LeukemiaRecurrent Childhood Anaplastic Large Cell LymphomaRecurrent Childhood Grade III Lymphomatoid Granulomatosis+4 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score5%

Leona Holmberg

Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium

Related
7 trials

Shared therapeutic areas:

Recurrent Childhood Large Cell LymphomaRecurrent Childhood Lymphoblastic LymphomaRecurrent Childhood Small Noncleaved Cell Lymphoma+1 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score3%

Mark W. Kieran, MD, PhD

Dana-Farber Cancer Institute

Related
6 trials

Shared therapeutic areas:

Unspecified Childhood Solid Tumor, Protocol Specific

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

Ryotaro Nakamura

City of Hope Medical Center

Related
10 trials

Shared therapeutic areas:

Leukemia, T-Cell Large Granular Lymphocytic

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

Brigitte C. Widemann, MD

National Cancer Institute (NCI)

Related
6 trials

Shared therapeutic areas:

Unspecified Childhood Solid Tumor, Protocol Specific

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

Steven Soignet, MD

Memorial Sloan Kettering Cancer Center

Related
6 trials

Shared therapeutic areas:

Unspecified Childhood Solid Tumor, Protocol Specific

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

Marisa Couluris, DO

University of South Florida

Related
5 trials

Shared therapeutic areas:

Unspecified Childhood Solid Tumor, Protocol Specific

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score1%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT00040781Phase 1PrincipalInvestigator

Gefitinib in Treating Children With Refractory Solid Tumors

Unspecified Childhood Solid Tumor, Protocol Specific
Completed
NCT01088763Phase 1PrincipalInvestigator

Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia

Childhood Atypical Teratoid/Rhabdoid TumorChildhood Central Nervous System ChoriocarcinomaChildhood Central Nervous System Germinoma+43 more
Terminated

All 2 trials loaded